158 related articles for article (PubMed ID: 34715251)
1. Inhibition of T-antigen expression promoting glycogen synthase kinase 3 impairs merkel cell carcinoma cell growth.
Houben R; Hesbacher S; Sarma B; Schulte C; Sarosi EM; Popp S; Adam C; Kervarrec T; Schrama D
Cancer Lett; 2022 Jan; 524():259-267. PubMed ID: 34715251
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell polyomavirus small tumour antigen activates the p38 MAPK pathway to enhance cellular motility.
Dobson SJ; Anene A; Boyne JR; Mankouri J; Macdonald A; Whitehouse A
Biochem J; 2020 Jul; 477(14):2721-2733. PubMed ID: 32639530
[TBL] [Abstract][Full Text] [Related]
3. RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.
Hesbacher S; Pfitzer L; Wiedorfer K; Angermeyer S; Borst A; Haferkamp S; Scholz CJ; Wobser M; Schrama D; Houben R
Oncotarget; 2016 May; 7(22):32956-68. PubMed ID: 27121059
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui WO
Int J Cancer; 2020 Mar; 146(6):1652-1666. PubMed ID: 31180579
[TBL] [Abstract][Full Text] [Related]
5. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
Schrama D; Sarosi EM; Adam C; Ritter C; Kaemmerer U; Klopocki E; König EM; Utikal J; Becker JC; Houben R
Int J Cancer; 2019 Aug; 145(4):1020-1032. PubMed ID: 30873613
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of p53 restriction in Merkel cell carcinoma cells are independent of the Merkel cell polyoma virus T antigens.
Houben R; Dreher C; Angermeyer S; Borst A; Utikal J; Haferkamp S; Peitsch WK; Schrama D; Hesbacher S
J Invest Dermatol; 2013 Oct; 133(10):2453-2460. PubMed ID: 23563200
[TBL] [Abstract][Full Text] [Related]
7. 4-[(5-Methyl-1H-pyrazol-3-yl)amino]-2H-phenyl-1-phthalazinone Inhibits MCPyV T Antigen Expression in Merkel Cell Carcinoma Independent of Aurora Kinase A.
Houben R; Alimova P; Sarma B; Hesbacher S; Schulte C; Sarosi EM; Adam C; Kervarrec T; Schrama D
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174007
[TBL] [Abstract][Full Text] [Related]
8. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.
Lyngaa R; Pedersen NW; Schrama D; Thrue CA; Ibrani D; Met O; Thor Straten P; Nghiem P; Becker JC; Hadrup SR
Clin Cancer Res; 2014 Apr; 20(7):1768-78. PubMed ID: 24526738
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Kohashi K; Kuwamoto S; Umekita Y; Oda Y
Cancer Sci; 2022 Jan; 113(1):251-260. PubMed ID: 34724284
[TBL] [Abstract][Full Text] [Related]
10. Merkel Cell Polyomavirus Large T Antigen is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells.
Houben R; Ebert M; Hesbacher S; Kervarrec T; Schrama D
Viruses; 2020 Oct; 12(10):. PubMed ID: 33066686
[TBL] [Abstract][Full Text] [Related]
11. Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma.
Ananthapadmanabhan V; Frost TC; Soroko KM; Knott A; Magliozzi BJ; Gokhale PC; Tirunagaru VG; Doebele RC; DeCaprio JA
JCI Insight; 2022 Jul; 7(13):. PubMed ID: 35801592
[TBL] [Abstract][Full Text] [Related]
12. Survivin is a therapeutic target in Merkel cell carcinoma.
Arora R; Shuda M; Guastafierro A; Feng H; Toptan T; Tolstov Y; Normolle D; Vollmer LL; Vogt A; Dömling A; Brodsky JL; Chang Y; Moore PS
Sci Transl Med; 2012 May; 4(133):133ra56. PubMed ID: 22572880
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma.
Choi JE; Verhaegen ME; Yazdani S; Malik R; Harms PW; Mangelberger D; Tien J; Cao X; Wang Y; Cieślik M; Gurkan J; Yazdani M; Jing X; Juckette K; Su F; Wang R; Zhou B; Apel IJ; Wang S; Dlugosz AA; Chinnaiyan AM
Neoplasia; 2019 Mar; 21(3):322-330. PubMed ID: 30797188
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell polyomavirus-positive Merkel cell carcinoma cells do not require expression of the viral small T antigen.
Angermeyer S; Hesbacher S; Becker JC; Schrama D; Houben R
J Invest Dermatol; 2013 Aug; 133(8):2059-64. PubMed ID: 23439392
[TBL] [Abstract][Full Text] [Related]
15. Merkel cell polyomavirus in Merkel cell carcinogenesis: small T antigen-mediates c-Jun phosphorylation.
Wu JH; Simonette RA; Nguyen HP; Rady PL; Tyring SK
Virus Genes; 2016 Jun; 52(3):397-9. PubMed ID: 26995220
[TBL] [Abstract][Full Text] [Related]
16. Characterization of functional domains in the Merkel cell polyoma virus Large T antigen.
Houben R; Angermeyer S; Haferkamp S; Aue A; Goebeler M; Schrama D; Hesbacher S
Int J Cancer; 2015 Mar; 136(5):E290-300. PubMed ID: 25208506
[TBL] [Abstract][Full Text] [Related]
17. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells.
Houben R; Adam C; Baeurle A; Hesbacher S; Grimm J; Angermeyer S; Henzel K; Hauser S; Elling R; Bröcker EB; Gaubatz S; Becker JC; Schrama D
Int J Cancer; 2012 Feb; 130(4):847-56. PubMed ID: 21413015
[TBL] [Abstract][Full Text] [Related]
18. High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.
Borchert S; Czech-Sioli M; Neumann F; Schmidt C; Wimmer P; Dobner T; Grundhoff A; Fischer N
J Virol; 2014 Mar; 88(6):3144-60. PubMed ID: 24371076
[TBL] [Abstract][Full Text] [Related]
19. [Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer].
Zur Hausen A
Pathologe; 2009 Dec; 30 Suppl 2():217-20. PubMed ID: 19921198
[TBL] [Abstract][Full Text] [Related]
20. MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.
Fan K; Gravemeyer J; Ritter C; Rasheed K; Gambichler T; Moens U; Shuda M; Schrama D; Becker JC
J Invest Dermatol; 2020 Jan; 140(1):56-65.e3. PubMed ID: 31283928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
